SCHEMBL14213827

SCHEMBL14213827

c1ccc(-c2ccc3cc(N(c4ccccc4)c4ccc(-c5ccc6c(ccn6-c6ccccc6)c5)cc4)ccc3c2)cc1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PLA2G4A P47712 1/20 0.40
HTR6 P50406 3/20 0.40
HDAC3 O15379 1/20 0.38
HDAC4 P56524 1/20 0.38
HDAC1 Q13547 1/20 0.38
HDAC7 Q8WUI4 1/20 0.38
HDAC2 Q92769 1/20 0.38
HDAC10 Q969S8 1/20 0.38
HDAC11 Q96DB2 1/20 0.38
HDAC8 Q9BY41 1/20 0.38
HDAC6 Q9UBN7 1/20 0.38
HDAC9 Q9UKV0 1/20 0.38
HDAC5 Q9UQL6 1/20 0.38
HSD11B1 P28845 1/20 0.36
ESR1 P03372 1/20 0.36
ESR2 Q92731 1/20 0.36
KDR P35968 1/20 0.34
FAAH O00519 1/20 0.34
BIRC5 O15392 1/20 0.34
LDHA P00338 2/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14213790 1.00 PLA2G4A (0.40) PLA2G4AHTR6HDAC3HDAC4HDAC1
SCHEMBL14213847 0.96 PLA2G4A (0.40) PLA2G4AHTR6HDAC3HDAC4HDAC1
SCHEMBL14213806 0.96 PLA2G4A (0.40) PLA2G4AHTR6HDAC3HDAC4HDAC1
SCHEMBL14213810 0.96 PLA2G4A (0.40) PLA2G4AHTR6HDAC3HDAC4HDAC1
SCHEMBL16356491 0.95 HTR6 (0.39) PLA2G4AHTR6HDAC3HDAC4HDAC1
SCHEMBL14213838 0.95 PLA2G4A (0.40) PLA2G4AHTR6HDAC3HDAC4HDAC1
SCHEMBL14213816 0.95 PLA2G4A (0.40) PLA2G4AHTR6HDAC3HDAC4HDAC1
SCHEMBL14213805 0.93 PLA2G4A (0.41) PLA2G4AHTR6HDAC3HDAC4HDAC1
SCHEMBL14213869 0.93 PLA2G4A (0.41) PLA2G4AHTR6HDAC3HDAC4HDAC1
SCHEMBL14213835 0.93 PLA2G4A (0.41) PLA2G4AHTR6HDAC3HDAC4HDAC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8507904-B2 Compound including indole derivative, organic electronic element using same, and terminal thereof DUKSAN HIGH METAL CO., LTD. (KR) 2013-08-13 US disclosed
US-8507904-B2 Compound including indole derivative, organic electronic element using same, and terminal thereof DUKSAN HIGH METAL CO., LTD. (KR) 2013-08-13 US disclosed
US-20120305906-A1 COMPOUND INCLUDING INDOLE DERIVATIVE, ORGANIC ELECTRONIC ELEMENT USING SAME, AND TERMINAL THEREOF DUKSAN HIGH METAL CO., LTD. (KR) 2012-12-06 US disclosed
US-20120305906-A1 COMPOUND INCLUDING INDOLE DERIVATIVE, ORGANIC ELECTRONIC ELEMENT USING SAME, AND TERMINAL THEREOF DUKSAN HIGH METAL CO., LTD. (KR) 2012-12-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120305906-A1 COMPOUND INCLUDING INDOLE DERIVATIVE, ORGANIC ELECTRONIC ELEMENT USING SAME, AND TERMINAL THEREOF INMT, IDO2, IDO1 PLA2G4A 3405/4885HTR6 249/4885HDAC3 4088/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.